Skip to main content

Find Clinical Trials

Home
Conditions
Breast Neoplasms

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

609 public trials 216 recruiting studies

Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Not Yet Recruiting

Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer

NCT07458204

Conditions: Breast Diseases, Breast Neoplasms, Disease Attributes, +9 more
Locations: Institut Godinot Reims, Champagne-Ardenne, France

View Trial Details

Not Yet Recruiting

A Phase II, Single-arm Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Eribulin in Pretreated Advanced Triple-negative Breast Cancer Harboring a PIK3CA Mutation

NCT07441512

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.

NCT07272642

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +32 more
Locations: Icon Cancer Centre Hollywood Nedlands, Western Australia, Australia

View Trial Details

Not Yet Recruiting

A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

NCT07423117

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer

NCT07419880

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Phase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Platinum Chemotherapy Versus Platinum Chemotherapy in the Treatment of Second-/Third-line Triple Negative Breast Cancer (TNBC)

NCT07413601

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: No. 17 Panjiayuan Nan Li, Chaoyang District, Beijing Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance

NCT07321015

Conditions: BRCA1/2 Mutation or Not, Breast Diseases, Breast Neoplasms, +7 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, China

View Trial Details

Not Yet Recruiting

Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)

NCT05128734

Conditions: Breast Cancer Triple Negative, Breast Diseases, Breast Neoplasms, +5 more
Locations: Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada

View Trial Details

Not Yet Recruiting

TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer

NCT07271992

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

NCT07256964

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details